Skip to search formSkip to main contentSkip to account menu

tipiracil 6.14 MG / Trifluridine 15 MG Oral Tablet [Lonsurf]

Known as: Lonsurf (trifluridine 15 MG / tipiracil 6.14 MG) Oral Tablet, Lonsurf 15 MG / 6.14 MG Oral Tablet, TRIFLURIDINE 15 mg / TIPIRACIL HYDROCHLORIDE 6.14 mg ORAL TABLET, FILM COATED [LONSURF] 
National Institutes of Health

Related topics

Related topics

14 relations
1-ButanolEthanolLactose MonohydrateLonsurf

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Long-term treatment response on therapy trifluridin/tipiracil (Lonsurf®) in patient with metastatic colorectal cancer
Kazuistika popisuje případ pacientky s kolorektálním karcinomem s nepříznivým biologickým chováním. Pacientka byla operována pro… 
Review
2019
Review
2019
Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer
Trifluridine/tipiracil (Lonsurf®) is a fixed-dose combination tablet comprising trifluridine, an antineoplastic nucleoside… 
2018
2018
Discovery and Development of Trifluridine/Tipiracil (Lonsurf ™)
2018
2018
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer
PurposeTrifluridine/tipiracil (FTD/TPI; TAS-102, Lonsurf®), a novel form of chemotherapy for metastatic colorectal cancer (mCRC… 
2018
2018
Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer
Trifluridine/tipiracil (TAS-102, Lonsurf®), a novel oral anti-tumor agent combining an anti-neoplastic thymidine-based nucleoside… 
2017
2017
Trifluridine/tipiracil in metastatic colorectal cancer: a guide to its use
Trifluridine/tipiracil (Lonsurf®; also known as TAS-102), an oral antimetabolite agent, is a welcome addition to the options… 
Review
2017
Review
2017
Metastatic Colorectal Cancer: Management with trifluridine/tipiracil
BACKGROUND: Treatment‐related adverse events (AEs) are common in patients with metastatic colorectal cancer (mCRC) receiving… 
Review
2016
Review
2016
Thymidine Phosphorylase in Cancer; Enemy or Friend?
Thymidine phosphorylase (TP) is a nucleoside metabolism enzyme that plays an important role in the pyrimidine pathway.TP… 
Review
2016
Review
2016
Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
Trifluridine/tipiracil (Lonsurf®) is a novel, orally active, antimetabolite agent comprised of trifluridine, a thymidine-based… 
2015
2015
[Initial Evaluation of the Efficacy and Safety of Tablets Containing Trifluridine and Tipiracil Hydrochloride--Safety Measures Devised by a Multidisciplinary Team Including a Pharmaceutical…
In May 2014, tablets containing both trifluridine and tipiracil hydrochloride (Lonsurf® tablets) were launched in Japan ahead of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)